GILEAD SCIENCES, INC. - 10%+ Owner at Xilio Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Issuer Symbol
XLO on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by GILEAD SCIENCES, INC. since 28 Jan 2025

Holdings reported by GILEAD SCIENCES, INC. for Xilio Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Prefunded Warrants (right to buy) 36,645,266 $27,480,284 $0.7499 26 Nov 2025 Direct Common Stock
Common Stock 9,105,451 $9,469,669 $1.04 18 Dec 2024 Direct
Series A Warrants (right to buy) 13,335,000 05 Jun 2025 Direct Common Stock
Series C Warrants (right to buy) 13,335,000 05 Jun 2025 Direct Common Stock
Series B Warrants (right to buy) 0 26 Nov 2025 Direct Common Stock

Transactions reported by GILEAD SCIENCES, INC. for Xilio Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.